Skip to main content
European Heart Journal logoLink to European Heart Journal
. 2022 Oct 1;44(6):535. doi: 10.1093/eurheartj/ehac536

Aetiologic diagnosis of coronary artery aneurysm in a patient with pancreatitis, dacryoadenitis, and sialadenitis

Antonio Iaconelli 1,2,, Giuseppe Rovere 3, Domenico D'Amario 4,5, Mattia Galli 6,7, Tommaso Sanna 8,9,2
PMCID: PMC9902151  PMID: 36181468

A 67-year-old man was admitted to our cardiology ward for a diagnostic work-up.

Coronary angiography (Panels A and B) and multidetector computed tomography coronary angiography (CTCA, Panels C and D) revealed an aneurysm of the proximal segment of the left anterior descending artery.

graphic file with name ehac536f1.jpg

Coronary artery aneurysm (CAA) is an infrequent finding and an aetiologic diagnosis is crucial for the treatment selection.1 Our patient reported a 10-year history of lymphadenopathy and recurrent episodes of sialadenitis, dacryoadenitis, prostatitis and pancreatitis. Prior biopsies of bone marrow, lymph nodes, prostate, salivary glands and pancreas showed lymphoplasmacytic infiltrates suggestive of an immune-mediated disease but a specific diagnosis had not been made.

A comprehensive diagnostic work-up revealed elevated IgG4 levels (440 mg/dL; n.v. ≤ 135 mg/dL) that, according to medical history and histological findings, confirmed the diagnosis of IgG4-related disease (IgG4-RD).

The patient was treated with corticosteroids and anticoagulants. One-year follow-up CTCA showed unchanged findings (Panels E and F), highlighting the importance to consider conservative approaches for this condition.

IgG4-RD often presents with pancreatitis, dacryoadenitis and sialadenitis but clinical manifestations are recognized in every organ system, including coronary arteries. Glucocorticoids are the first-line treatment of IgG4-RD, potentially resulting in disease remission.2 The history of pancreatitis, sialadenitis, dacryoadenitis and lymphadenopathy in a patient with CAA should alert cardiologists to suspect IgG4-RD.

Guarantor: The scientific guarantor of this publication is Antonio Iaconelli as corresponding author.

Statistics and biometry: No complex statistical methods were necessary for this paper.

Informed consent: Written informed consent was obtained from the patient involved in this study.

Methodology: Case.

Funding: None declared.

Contributor Information

Antonio Iaconelli, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Francesco Vito, 1–00168 Rome, Italy; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Giuseppe Rovere, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Francesco Vito, 1–00168 Rome, Italy.

Domenico D'Amario, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Francesco Vito, 1–00168 Rome, Italy; Department of Cardiovascular Sciences, Catholic University of the Sacred Heart (UCSC), Rome, Italy.

Mattia Galli, Department of Cardiovascular Sciences, Catholic University of the Sacred Heart (UCSC), Rome, Italy; Maria Cecilia Hospital, GVM Care and Research, Cotignola, Italy.

Tommaso Sanna, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Francesco Vito, 1–00168 Rome, Italy; Dipartimento di Scienze Cardiovascolari, Università Cattolica del Sacro Cuore (UCSC), Rome, Italy.

 

  • 1. Chrissoheris MP, Donohue TJ, Young RS, Ghantous A. Coronary artery aneurysms. Cardiol Rev 2008;16:116–123. [DOI] [PubMed] [Google Scholar]
  • 2. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet 2015;385:1460–1471. [DOI] [PubMed] [Google Scholar]

Articles from European Heart Journal are provided here courtesy of Oxford University Press

RESOURCES